Pharmaceutical Company

Lidoflak ® Tablets

Each Tablet contain :

  • Silodosin 8 mg

  • treatment of the signs and symptoms of benign prostatic hyperplasia (BPH)
  • one tablet once daily
  • Severe renal impairment (CCr < 30 mL/min)
  • Severe hepatic impairment.
  • Concomitant administration with strong Cytochrome P450 3A4 (CYP3A4) inhibitors (e.g., ketoconazole, clarithromycin, itraconazole, ritonavir
  • Patients with a history of hypersensitivity to silodosin or any of the ingredients of Lidoflak

box contain 3o capsules 

  • (silodosin), a selective alpha-1 adrenergic receptor antagonist, is indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH).